Tag Archives: health

Op-Ed in Forbes on the Threat to Philanthropy


This week, Howard Husock extols the benefits of venture philanthropy through this Forbes op-ed. In the op-ed, Husock points out that private entities conduct a significant portion of applied research toward new drug development as referenced in this 2008 Manhattan Institute paper, “The Truth About Drug Innovation”, co-authored by two researchers from the Tufts University Center for the Study of Drug Development, and Institute Fellow Benjamin Zycher: “. . .among. . . thirty-five drugs and Read More >

Business and Investments, Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Bavarian Nordic CEO Paul Chaplin in San Jose Mercury News: Why an Ebola Vaccine Still Matters


The San Jose Mercury News this weekend published an op-ed by Paul Chaplin, the CEO of Bavarian Nordic and a co-chair of the Alliance for Biosecurity which discussed the continuing need to develop an Ebola vaccine – as well as continued federal investments in the programs which fund such research. As Dr. Chaplin notes, all of the Ebola drug and vaccine candidates currently in development have received U.S. federal funding. Why do medical countermeasures against Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

CDC: It’s Not Too Late to Get This Season’s Flu Vaccine


Politico Pro’s Brett Norman today writes that the Centers for Disease Control and Prevention (CDC) continues to encourage the public to get the flu vaccine since hospitalizations related to the flu are on the rise. The article states that flu-related hospitalizations of those over 65 jumped to 92 per 100,000 this week, up from 52 last week. “The fact that this season’s flu vaccine is poorly matched with the dominant strains circulating makes it more Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Updated Legal and Regulatory Frameworks Needed for Biosimilars

Jim Greenwood

Biosimilars raise novel and complex questions of science and law that require updated legal and regulatory frameworks. We call on the FDA to release final guidance on processes and scientific criteria for the approval of biosimilars, outline its approach to naming and labeling, and clarify its conditions for determining a biosimilar to be interchangeable with its reference biological. There has been positive momentum recently, however, we believe the appropriate way to develop policy on such Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Cervical Health Awareness Month: 5 Things You Need to Know about HPV

scientist, lab

Approximately 79 million Americans have HPV (human papillomavirus), which is a major cause of cervical cancer. HPVs are a group of more than 150 related viruses. More than 40 of these viruses can be easily spread through direct skin-to-skin contact. Most infections with high-risk HPVs do not cause cancer. Many HPV infections disappear within two years, but infections lasting several years may increase the risk of developing cancer. High-risk HPV infection accounts for approximately five Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,